Skip to content
HowShorted

How shorted was Rain Oncology Inc.? RAIN

Rain Oncology Inc. left the US market in 2024. This page is a frozen archive of its reported short interest, ending 12 Jan 2024. The ticker RAIN no longer refers to this company; it currently belongs to Rain Enhancement Technologies.
1.82%
of shares outstanding reported short ยท settlement date 12 Jan 2024
vs previous report
+0.62
5 reports (~10 weeks)
+0.13
days to cover
2.33
Aggregate net short position time series for Rain Oncology Inc.

Markers along the chart's base: โ–ฒ results announced (an 8-K reporting results was filed) โ–ฒ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Rain Oncology Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
9 Nov 20231.69% 31 Oct 20231.40% 15 Nov 2023โˆ’0.29
10 Aug 20233.26% 31 Jul 20232.96% 15 Aug 2023โˆ’0.30
11 May 20233.13% 28 Apr 20233.07% 15 May 2023โˆ’0.06
9 Mar 20231.41% 28 Feb 20231.75% 15 Mar 2023+0.34
14 Nov 20221.00% 31 Oct 20220.93% 15 Nov 2022โˆ’0.07
3 Mar 20222.37% 28 Feb 20222.34% 15 Mar 2022โˆ’0.03
10 Nov 20213.09% 29 Oct 20213.12% 15 Nov 2021+0.03

Fails to deliver

The SEC's fails-to-deliver figure for RAIN: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
67,191
26 Aug 2026
Highest in window
156,674
4 Aug 2026
Days with a balance
135
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Rain Oncology Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 157K shares.

Share on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare

History

Full reported short interest history
Settlement dateShort %Change
12 Jan 20241.82%+0.62
29 Dec 20231.20%โˆ’0.28
15 Dec 20231.48%+0.05
30 Nov 20231.43%+0.03
15 Nov 20231.40%โˆ’0.29
31 Oct 20231.69%+0.47
13 Oct 20231.22%โˆ’0.14
29 Sep 20231.36%โˆ’0.58
15 Sep 20231.94%โˆ’0.43
31 Aug 20232.37%โˆ’0.59
15 Aug 20232.96%โˆ’0.30
31 Jul 20233.26%โˆ’0.33
14 Jul 20233.59%โˆ’0.38
30 Jun 20233.97%โˆ’0.19
15 Jun 20234.16%โˆ’0.34
31 May 20234.50%+1.43
15 May 20233.07%โˆ’0.06
28 Apr 20233.13%+0.21
14 Apr 20232.92%+0.42
31 Mar 20232.50%+0.75
15 Mar 20231.75%+0.34
28 Feb 20231.41%โˆ’0.15
15 Feb 20231.56%+0.08
31 Jan 20231.48%+0.50
13 Jan 20230.98%+0.05
30 Dec 20220.93%โˆ’0.06
15 Dec 20220.99%+0.06
30 Nov 20220.93%0.00
15 Nov 20220.93%โˆ’0.07
31 Oct 20221.00%+0.02
14 Oct 20220.98%โˆ’0.06
30 Sep 20221.04%โˆ’0.03
15 Sep 20221.07%+0.07
31 Aug 20221.00%โˆ’0.92
15 Aug 20221.92%+0.50
29 Jul 20221.42%โˆ’0.22
15 Jul 20221.64%โˆ’1.06
30 Jun 20222.70%โˆ’0.50
15 Jun 20223.20%โˆ’0.02
31 May 20223.22%+0.30
13 May 20222.92%+0.09
29 Apr 20222.83%+0.43
14 Apr 20222.40%+0.07
31 Mar 20222.33%โˆ’0.01
15 Mar 20222.34%โˆ’0.03
28 Feb 20222.37%+0.10
15 Feb 20222.27%โˆ’0.97
31 Jan 20223.24%โˆ’0.21
14 Jan 20223.45%โˆ’0.13
31 Dec 20213.58%+0.31
15 Dec 20213.27%โˆ’0.03
30 Nov 20213.30%+0.18
15 Nov 20213.12%+0.03
29 Oct 20213.09%โˆ’0.04
15 Oct 20213.13%โˆ’0.25
30 Sep 20213.38%โˆ’0.16
15 Sep 20213.54%+0.11
31 Aug 20213.43%+0.08
13 Aug 20213.35%โ€“

Newest first. Scroll inside the table for earlier dates, back to 13 Aug 2021.

Frequently asked questions

How shorted was Rain Oncology Inc.?
Rain Oncology Inc. left the US market in 2024. Its final reported figure was 1.82% of shares outstanding for settlement date 12 Jan 2024, per FINRA's consolidated short interest report; this page preserves its full history.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this RAIN's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is RAIN's days to cover?
2.33 days for settlement date 12 Jan 2024: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.